To our knowledge, our study is the first to unravel the role of TTN-AS1/miR-513a-5p/SFN pathway in CCA pathogenesis, which might be a promising therapeutic target for patients with CCA. The gene discussed is SFN; the disease is cholangiocarcinoma.